Related Experiment Videos
Morphological and cellular basis for airflow limitation in smokers
M Saetta1, R Finkelstein, M G Cosio
1Institute of Occupational Medicine, University of Padova, Italy.
The European Respiratory Journal
|August 1, 1994
Summary
Smokers develop airflow limitation due to small airway narrowing or loss of lung elastic recoil. Differentiating between centrilobular emphysema and panlobular emphysema is key to understanding chronic obstructive pulmonary disease (COPD) pathogenesis in smokers.
Area of Science:
- Pulmonary Medicine
- Respiratory Physiology
- Pathology
Background:
- Airflow limitation in smokers involves increased airway resistance, predominantly in small airways, and reduced elastic recoil.
- Smokers exhibit airway wall abnormalities, including epithelial damage, inflammation, and fibrosis, leading to lumen narrowing.
- These changes contribute to airway hyperresponsiveness and decreased forced expiratory volume in one second (FEV1).
Purpose of the Study:
- To differentiate the mechanisms of airflow limitation in smokers based on emphysema type: centrilobular emphysema (CLE) and panlobular emphysema (PLE).
- To investigate the correlation between small airway abnormalities, loss of elastic recoil, and airflow limitation in CLE and PLE.
- To elucidate the distinct pathogenetic pathways for CLE and PLE in smokers.
Main Methods:
- Morphometric analysis of airways in smokers.
- Assessment of airway resistance and elastic recoil using lung function tests (e.g., pressure-volume curves).
- Correlation analysis between airway pathology, lung mechanics, and emphysema type.
Main Results:
- Smokers with CLE show significant small airway abnormalities correlated with flow limitation, independent of elastic recoil.
- Smokers with PLE exhibit less severe airway abnormalities, with airflow limitation linked to loss of elastic recoil.
- Microscopic emphysema in PLE can be present even with mild FEV1 reduction.
Conclusions:
- CLE pathogenesis in smokers may involve an airborne mechanism and airway hyperresponsiveness.
- PLE pathogenesis in smokers might be bloodborne, potentially related to alpha 1-antiprotease dysfunction.
- Distinguishing between CLE and PLE is crucial for understanding COPD development in smokers.